Regular intellectual property news from Australia and overseas.
Applera and Roche settle rt-PCR litigation
May 9 – Applera and Roche Diagnostics have settled litigation in relation to a contractual dispute involving the commercialisation rights to PCR and real-time PCR technology. Under the undisclosed terms, it is understood that Applera's ABI Group will be the sole licensor of Roche's patents covering methods and reagents for PCR and real-time PCR for life science research and other applications. Applera has also obtained a diagnostics licence, without the right to sub-license, of Roche's nucleic acid technology patents. In addition, Roche and Applera have granted each other licenses to PCR technology for research and diagnostics. This includes the right for Roche to manufacture real-time PCR instruments for a third party under certain conditions.
[Source: GenomeWeb News]
